Thus, overexpression of CCAT2 might be responsible for the mitigation of the tumor suppression ability of miR-34a, which has been also shown to promote the activation of cellular senescence programs by downregulating the FOXM1 oncogene independent of CCAT2 [107]. This evidence concerns the gene CCAT2 and neoplasm.